Neurocrine Biosciences shares owned by Mackenzie Financial
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Mackenzie Financial
from 13F filings
Historical chart of Mackenzie Financial investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Neurocrine Biosciences by Mackenzie Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $12M | 85k | 140.38 |
| 2025-06-30 | $9.5M | 76k | 125.69 |
| 2025-03-31 | $9.5M | 86k | 110.60 |
| 2024-12-31 | $6.9M | 55k | 125.00 |
| 2024-09-30 | $10M | 87k | 115.22 |
| 2024-06-30 | $12M | 89k | 137.67 |
| 2024-03-31 | $13M | 92k | 137.92 |
| 2023-12-31 | $13M | 97k | 131.76 |
| 2023-09-30 | $11M | 96k | 110.51 |
| 2023-06-30 | $8.7M | 92k | 94.48 |
| 2023-03-31 | $4.9M | 48k | 101.22 |
| 2022-12-31 | $4.7M | 40k | 119.44 |
| 2022-09-30 | $3.8M | 36k | 106.22 |
| 2022-06-30 | $4.2M | 43k | 97.48 |
| 2022-03-31 | $2.8M | 30k | 93.76 |
| 2021-12-31 | $868k | 10k | 85.16 |
| 2021-09-30 | $1.4M | 15k | 95.88 |
| 2021-06-30 | $945k | 9.7k | 97.33 |
| 2021-03-31 | $957k | 9.8k | 97.21 |
| 2020-12-31 | $1.6M | 17k | 95.85 |
| 2020-09-30 | $1.6M | 16k | 96.17 |
| 2020-06-30 | $1.0M | 8.3k | 122.03 |
| 2020-03-31 | $652k | 7.5k | 86.53 |
| 2019-12-31 | $815k | 7.6k | 107.51 |
| 2019-09-30 | $795k | 8.8k | 90.12 |
| 2019-06-30 | $612k | 7.3k | 84.41 |
| 2019-03-31 | $766k | 8.7k | 88.11 |
| 2018-12-31 | $533k | 7.5k | 71.36 |
| 2018-09-30 | $711k | 5.8k | 122.90 |
| 2018-06-30 | $278k | 2.8k | 98.09 |
| 2018-03-31 | $295k | 3.6k | 82.96 |